Atosiban versus betamimetics in the treatment of preterm labour in Germany: An economic evaluation

BMC Pregnancy and Childbirth

Volumn 9, Issue , 2009, Pages

  Wex, Jaro ^a   Connolly, Mark ^b   Rath, Werner ^c  

^a PharmArchitecture Limited   (United Kingdom)

^b Global Market Access Solutions   (Switzerland)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FENOTEROL; PLACEBO; ARGIPRESTOCIN; DRUG DERIVATIVE; UTERUS SPASMOLYTIC AGENT;

ANXIETY; ARTICLE; BOLUS INJECTION; CLINICAL TRIAL; COST CONTROL; DRUG COST; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSPNEA; ECONOMIC EVALUATION; FETUS DISEASE; GERMANY; HEALTH ECONOMICS; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; HYPOTENSION; LUNG EDEMA; NAUSEA; PREMATURE LABOR; SIDE EFFECT; SYNCOPE; SYSTEMATIC REVIEW; TACHYCARDIA; THORAX PAIN; TOCOLYSIS; TREMOR; VOMITING; COST BENEFIT ANALYSIS; DRUG TOXICITY; ECONOMICS; FEMALE; META ANALYSIS; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICAL MODEL; STATISTICS;

ADRENERGIC BETA-AGONISTS; COST-BENEFIT ANALYSIS; DRUG COSTS; DRUG TOXICITY; FEMALE; GERMANY; HUMANS; MODELS, ECONOMETRIC; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TOCOLYTIC AGENTS; VASOTOCIN;

EID: 67650751818     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-9-23     Document Type: Article

References (35)

1. World Health Organization The prevention of perinatal mortality and morbidity. Report of a WHO Expert Committee World Health Organ Tech Rep Series 1970, 457:1-60.
2. Burke C Morrison JJ Perinatal factors and preterm delivery in an Irish obstetric population J Perinat Med 2000, 28:49-53. 10.1515/JPM.2000.007 10765514
3. Martin JA Hamilton BE Sutton PD Ventura SJ Menacker F Kirmeyer S Births: final data for 2004 Natl Vital Stat Rep 2006, 55:1-101.
4. Institute of Medicine, Committee on Understanding Premature Birth and Assuring Healthy Outcomes Preterm Birth: Causes, Consequences, and Prevention Washington DC: National Academies Press Behrman RE, Butler AS 2007.
5. Goldenberg RL Culhane JF Iams JD Romero R Epidemiology and causes of preterm birth Lancet 2008, 371:75-84. 10.1016/S0140-6736(08)60074-4 18177778
6. Costeloe K Hennessy E Gibson AT Marlow N Wilkinson AR The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability Pediatrics 2000, 106:659-671. 10.1542/peds.106.4.659 11015506
7. Wood NS Marlow N Costeloe K Gibson AT Wilkinson AR Neurologic and developmental disability after extremely preterm birth. EPICure Study Group N Eng J Med 2000, 343:378-384. 10.1056/NEJM200008103430601
8. Husslein P Quartorolo JP Review of clinical experience with atosiban and the Tractocile Efficacy Assessment Survey in Europe (Treasure) study protocol Int J Clin Pract 2003, 57:121-127. 12661796
9. King JF Flenady V Cole S Thornton S Cyclo-oxygenase (COX) inhibitors for treating preterm labour Cochrane Database of Systematic Reviews 2005, 2:CD001992.
10. Crowther CA Hiller JE Doyle LW Magnesium sulphate for preventing preterm birth in threatened preterm labour Cochrane Database of Systematic Reviews 2002, 4:CD001060.
11. Whitworth M Quenby S Prophylactic oral betamimetics for preventing preterm labour in singleton pregnancies Cochrane Database of Systematic Reviews 2008, 1:CD006395.
12. Anotayanonth S Subhedar NV Neilson JP Harigopal S Betamimetics for inhibiting preterm labour Cochrane Database of Systematic Reviews 2004, 4:CD004352.
13. King JF Flenady V Papatsonis D Dekker G Carbonne B Calcium channel blockers for inhibiting preterm labour Cochrane Database of Systematic Reviews 2003, 1:CD002255.
14. Papatsonis D Flenady V Cole S Liley H Oxytocin receptor antagonists for inhibiting preterm labour Cochrane Database of Systematic Reviews 2005, 3:CD004452.
15. Beinder E Dudenhausen J Feige A Hackelöhr BJ Hecher K Rath W et al Medikamentöse Wehenhemmung bei drohender Frühgeburt AWMF 015/ 025. Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V 2006 http://www.uni-duesseldorf.de/AWMF/ll/015-025.htm
16. Worldwide Atosiban versus Beta-agonists Study Group Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour BJOG 2001, 108:133-142. 11236112
17. Hayes E Moroz L Pizzi L Baxter J A cost decision analysis of 4 tocolytic drugs Am J Obstet Gynecol 2007, 197:383.e1-383.e6. 10.1016/ j.ajog.2007.06.052
18. Chan J Cabrol D Ingemarsson I Marsal K Moutquin JM Fisk NM Pragmatic comparison of beta2-agonist side effects within the Worldwide Atosiban versus Beta Agonists study Eur J Obstet Gynecol Reprod Biol 2006, 128:135-141. 10.1016/j.ejogrb.2006.01.030 16504369
19. Bax L Yu LM Ikeda N Tsuruta H Moons KGM Development and validation of MIX: Comprehensive free software for meta-analysis of causal research data BMC Med Res Methodol 2006, 6:50. 1626481 17038197 10.1186/ 1471-2288-6-50
20. GEOS Online Grouper 2008 Gesellschaft für den Einsatz offener Systeme mbH http://www.geos-online.de/OnlineGrouper/login.aspx
21. Rote Liste Online. Internet-Version für die Fachkreise http://www.rote-liste.de
22. European Atosiban Study Group The oxytocin antagonist atosiban versus the B-agonist Terbutaline in the treatment of preterm labour. A randomised, double-blind, controlled study Acta Obstet Gynecol Scand 2001, 80:413-422. 11328217
23. French/Australian Atosiban Investigators Group Treatment of preterm labor with the oxytocin antagonist atosiban: A double-blind, randomized, controlled comparison with salbutamol Eur J Obstet Gynecol Reprod Biol 2001, 98:177-185. 10.1016/S0301-2115(01)00331-1 11574128
24. Moutquin J-M Sherman D Cohen H Mohide PT Hochner-Celnikier D Fejgin M et al Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: A multicenter effectiveness and safety study Am J Obstet Gynecol 2000, 182:1191-1199. 10.1067/ mob.2000.104950 10819857
25. Shim JY Park YW Yoon BH Cho YK Yang JH Lee Y et al Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women BJOG 2006, 113:1228-1234. 10.1111/j.1471-0528.2006.01053.x 16978233
26. Goodwin TM Valenzuela GJ Silver H Creasy G Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group Obstet Gynecol 1996, 88:331-336. 10.1016/ 0029-7844(96)00200-1 8752234
27. Husslein P Roura LC Dudenhausen JW Helmer H Frydman R Rizzo N et al Atosiban versus usual care for the management of preterm labor J Perinat Med 2007, 35:305-313. 10.1515/JPM.2007.078 17614750
28. Heinen-Kammerer T Motzkat K Rychlik R Kosten-Effektivitäts-Analyse verschiedener Tokolyse-Schemata. Vergleich von Atosiban, Fenoterol, Fenoterol in Verbindung mit Magnesiumsulfat und Fenoterol als Bolusgabe Krankenhauspharmazie 2003, 24:45-49.
29. Rath W Bartz C Medikamentöse Wehenhemmung - aktueller Stand. Tocolysis in Preterm Labour - Current Status GebFra 2005, 65:570-579.
30. Husslein P Roura LC Dudenhausen J Helmer H Frydman R Rizzo N et al Clinical practice evaluation of atosiban in preterm labour management in six European countries, TREASURE study group BJOG 2006, 113(Suppl 3):105-110. 17206976
31. Ferriols R Nicolás J Alós M Evaluación farmacoeconómica de dos protocolos de tocolisis para la inhibición del parto premature Farm Hosp 2005, 29:18-25. 10.1016/ S1130-6343(05)73631-X 15773798
32. Hrubý K Srovnání nákladù na léèbu pøedèasného porodu atosibanem nebo beta-sympatomimetiky z perspektivy plátce zdravotní péèe - farmakoekonomický model Ceska Gynekol 2004, 69:96-105. 15141520
33. Essed GG Eskes TK Jongsma HW A randomized trial of two beta-mimetic drugs for the treatment of threatening early labor: Clinical results in a prospective comparative study with ritodrine and fenoterol Eur J Obstet Gynecol Reprod Biol 1978, 8:341-8. 10.1016/0028-2243(78)90046-1
34. Anonymous Treatment of preterm labor with the beta-adrenergic agonist ritodrine. The Canadian Preterm Labor InvestigationGroup N Engl J Med 1992, 327:308-12. 1620169
35. Norwitz ER Bahtiyar MO Sibai BM Defining standards of care in maternal-fetal medicine Am J Obstet Gynecol 2004, 191:1491-1496. 10.1016/ j.ajog.2004.06.043 15507989